<info type="GeneOrGeneProduct">PIK3CA</info> mutations in endoscopic biopsy and surgically resected specimens of <info type="DiseaseOrPhenotypicFeature">esophageal squamous cell carcinoma</info>.

BACKGROUND: <info type="GeneOrGeneProduct">PIK3CA</info> mutations are expected to be potential therapeutic targets for <info type="DiseaseOrPhenotypicFeature">esophageal squamous cell carcinoma</info> (<info type="GeneOrGeneProduct">ESCC</info>). We aimed to clarify the concordance between <info type="GeneOrGeneProduct">PIK3CA</info> mutations detected in endoscopic biopsy specimens and corresponding surgically resected specimens. METHODS: We examined five hotspot mutations in the <info type="GeneOrGeneProduct">PIK3CA</info> gene (<info type="SequenceVariant">E542K</info>, <info type="SequenceVariant">E545K</info>, <info type="SequenceVariant">E546K</info>, <info type="SequenceVariant">H1047R</info>, and <info type="SequenceVariant">H1047L</info>) in formalin-fixed and paraffin-embedded tissue sections of paired endoscopic biopsy and surgically resected specimens from <info type="OrganismTaxon">181 patients</info> undergoing curative resection for <info type="DiseaseOrPhenotypicFeature">ESCC</info> between <info type="ChemicalEntity">2000</info> and <info type="ChemicalEntity">2011</info> using a <info type="ChemicalEntity">Luminex</info> technology-based multiplex gene mutation detection kit. RESULTS: Mutation analyses were successfully performed for both endoscopic biopsy and surgically resected specimens in all the cases. A <info type="GeneOrGeneProduct">PIK3CA</info> mutation was detected in either type of specimen in <info type="ChemicalEntity">13 cases</info> (<info type="ChemicalEntity">7.2%</info>, <info type="ChemicalEntity">95%</info> confidence interval: <info type="ChemicalEntity">3.9-12.0</info>). The overall concordance rate, positive predictive value, and negative predictive value were <info type="ChemicalEntity">98.3%</info> (<info type="ChemicalEntity">178/181</info>), <info type="ChemicalEntity">90.9%</info> (<info type="ChemicalEntity">10/11</info>), and <info type="ChemicalEntity">98.8%</info> (<info type="ChemicalEntity">168/170</info>), respectively. Among patients with a <info type="GeneOrGeneProduct">PIK3CA</info> mutation detected in both types of specimens, the concordance between <info type="GeneOrGeneProduct">PIK3CA</info> mutation genotypes was <info type="ChemicalEntity">100%</info>. There were <info type="ChemicalEntity">three cases</info> with a discordant mutation status between the types of specimens (<info type="GeneOrGeneProduct">PIK3CA</info> mutation in surgically resected specimen and wild-type in biopsy specimen in <info type="ChemicalEntity">two cases</info>, and the opposite pattern in <info type="ChemicalEntity">one case</info>), suggesting possible intratumoral heterogeneity in the <info type="GeneOrGeneProduct">PIK3CA</info> mutation status. CONCLUSIONS: The <info type="GeneOrGeneProduct">PIK3CA</info> mutation status was highly concordant between endoscopic biopsy and surgically resected specimens from the same patient, suggesting that endoscopic biopsy specimens can be clinically used to detect <info type="GeneOrGeneProduct">PIK3CA</info> mutations in patients with <info type="DiseaseOrPhenotypicFeature">ESCC</info>.